George Kostanteen

▶️ LEADERSHIP: ▪ Led a team of 65 employees, with 9 direct reports, directly reporting to the International Growth Emerging Markets Vice President. ▪ Responsible for a $70M USD budget with full P&L responsibility, forming the financial backbone for strategic initiatives and market expansions. ▶️ PROFESSIONAL HIGHLIGHTS: ▪ Led cross-functional collaboration across international and regional teams, successfully integrating pharma & healthcare businesses across MEA. Spearheaded the development of Go-To-Market model, driving 25% sales growth in 2023, 18% in 2024, and 15% EBIT improvement. ▪ Established strategic partnerships with 25+ distributors and developed comprehensive 360-degree distributor support programs, including training, revamped commercial terms, optimized pricing model, and a performance rebate program. These initiatives led to greater market penetration, 10% profitability increase, and consistent 20% revenue growth over past 3 years. ▪ Developed strong relationships with key industry stakeholders, including key accounts, KOLs, chain pharmacies, hospitals, and e-commerce. These efforts resulted in 15% increase in customer satisfaction & consistent double-digit sales growth during last 3 years. ▪ Spearheaded market share expansion, achieving 4% gain in DE & 3% gain in CL, securing market leadership positions of 25% and 40% respectively. ▪ Led the launch of the blockbuster Systane portfolio and spearheaded commercial strategies and multi-channel engagement, including distribution channels, digital tools, ecosystem, e-commerce, and tenders. These efforts successfully built a $30M brand, achieving consistent double-digit growth over 4 years. ▪ Executed market access and pricing strategy resulting in $3M profit increase. Established 3-year strategic plan, outlining pipelines & market expansions, setting a framework for sustained growth. ▪ Developed 3 team members to global positions, recognized with global awards as leader of the year and Win-In-Innovation.

▶️ LEADERSHIP: ▪ Managed a team of 48 employees with 8 direct reports, overseeing strategic execution under the guidance of the International Growth Emerging Markets Vice President. ▪ Directed annual sales objectives for the Surgical division, managing a total business of $65M USD with full P&L responsibility. ▪ Built strong KOLs network, establishing the company as a trusted partner and played critical role in CSR to enhance company's brand image. ▶️ PROFESSIONAL HIGHLIGHTS: ▪ Increased market share by 5%, reaching 59% in Cataract and 68% in Vit Ret segments, solidifying market dominance. ▪ Led strategic initiatives to optimize internal processes, achieving a 20% improvement in operational efficiency and a reduction in lead times. Meanwhile identified customer pain points, leading to the development of customer-centric solutions and a 95% customer satisfaction rate. ▪ Renovated distributors commercial terms, and introduced new pricing models, rebate programs, and pay-for-performance, resulting in a 10% profitability increase. ▪ Implemented innovative sales training programs that boosted the team's selling skills, contributing to a 15% increase in individual sales performance within the division. Collaborated cross-functionally with global teams to successfully introduce new product launches, achieving a rapid market adoption rate.

▶️ LEADERSHIP: ▪ Managed a team of 35 employees, including 6 direct reports, reporting directly to President International Markets. ▪ Led the strategic direction, team, and P&L management of a $50M USD business, specializing in generics, legacy branded pharmaceuticals, and oncology products. ▶️ PROFESSIONAL HIGHLIGHTS: ▪ Optimized sales team efficiency and structure, achieving remarkable sales double-digit growth of a 21% in 2017 and 18% in 2018. ▪ Directed the Marketing Authorization (MA) transfer of 2 products from Leo & Roche across MENA, leading cross-functional teams from inception to successful execution. ▪ Initiated and spearheaded a business transition in Saudi Arabia to a new partner and recovered $1.5M USD in bad debt. ▪ Implemented and led a market access and pricing strategy in Algeria, achieving an additional 1M units sold per year. ▪ Renegotiated distributors terms, optimizing and reducing sales commissions/discounts, hence significantly increased profitability by 8%. ▪ Transitioned the Go-To-Market strategy to a distributor model following a corporate strategy shift, achieving approximately $5M USD in cost savings for MENA operations.

▶️ LEADERSHIP: ▪ Led a team of 63 employees with 9 direct reports, directly reporting to the General Manager of the Middle East cluster. ▪ Managed a budget of $80M USD with full P&L responsibility and directing commercial terms, distribution channels, and Key Account Management (KAM). ▪ Assumed the role of Compliance Champion, playing a pivotal role in embedding Novartis compliance culture and policies across the organization. ▶️ PROFESSIONAL HIGHLIGHTS: ▪ Developed and executed a sales force strategy, optimizing performance and operation through implementing an innovative hyper-growth model and team restructuring, achieving 19 % sales growth and operational excellence. ▪ Initiated a strategic initiative to optimize the product sales mix, achieving a notable 15% improvement. ▪ Designed and implemented the Tail Project model in collaboration with distributors to effectively manage the mature portfolio, contributing to high double-digit growth of 34% in 2015.

▶️ LEADERSHIP: Managed a team of 15 direct reports, reporting directly to the Asia Pacific Vice President, and oversaw a budget of $35M USD with full P&L responsibility. ▶️ PROFESSIONAL HIGHLIGHTS: ▪ Crafted a shift from a distributor model to a Go-To-Market strategy, driving a 36% CAGR in sales growth, surpassing the strategic plan by 9%. ▪ Led successful transformative distributorship changes, tripling North Africa sales to $6M USD within 2 years. ▪ Awarded Leadership in the Face of Adversity by Novartis/Ciba Vision APAC region.

Business and portfolio spine off from J&J and (Currently Kenvue) ▶️ LEADERSHIP: Established J&J Healthcare & OTC business unit, integrating Pfizer CHC and Janssen products, and developed marketing strategies across Pharma, OTC, and FMCG categories. ▶️ PROFESSIONAL HIGHLIGHTS: ▪ Led a high-performing team and achieved a 24% sales growth and a 5% increase in market share through targeted commercial and marketing campaigns. ▪ Innovated in-store visibility, boosting category leadership, and launched a diverse product portfolio, driving recommendations and a 20% increase in sales.

Business and portfolio acquired by (Currently Haleon) ▶️ LEADERSHIP: Led global brands strategies and execution, driving sales growth and market expansion across key segments (Pain relief, dermatology, skincare, Cold/Flu, and multivitamins). ▶️ PROFESSIONAL HIGHLIGHTS: ▪ Developed and implemented innovative consumer marketing strategies that boosted brand visibility and market share, establishing Novartis as the top Healthcare & OTC company in the ME region with 45% market share as per IQVIA. ▪ Initiated Novartis business operations in Iran and Iraq, achieving sales milestones totaling $15M USD within 2 years. ▪ Recognized with the Novartis global award for Best Marketing Innovation with successful rollout across multiple global markets.

▶️ PROFESSIONAL HIGHLIGHTS: ▪ Led the startup, office setup, and launch of Novartis ICU & Medical Nutrition in the Middle East, rapidly achieving the #2 market position in the Gulf Region within 2 years. ▪ Hired & spearheaded a specialized sales and promotion team across Middle East markets, instrumental in driving market penetration and continuous expansion of Novartis Medical Nutrition offerings.

▶️ PROFESSIONAL HIGHLIGHTS: ▪ Launched & Promoted Total Parenteral & Enteral Nutrition range, Plasma substitute pharmaceutical and medical devices, Immuno-suppressive product in kidney transplantation (ATG) and anesthetic agent (Propofol) in both governmental & private sectors. ▪ Led UAE distributor partnership. ▪ Developed and executed marketing campaigns and HCPs communication as marketing lead.

Executed sales, trade promotion and doctor's detailing of Cardio-vascular and Antihypertensive drugs (Coversyl, Natrilix, Trivastal & Daflon) as well as Oral Anti-diabetic Product (Diamicron) In both private & governmental sectors. In addition to national tender account management across Saudi Arabia.

Launched and Promoted diversified pharmaceutical products and therapeutic segments such as Anti-Diabetic/Insulin range (Humulin), Antibiotic range (Ceclor, Nebcin & Mandol), and Antidepressant (Prozac) in both Private & Governmental sectors.